Naltrexone, a therapeutic alternative in Darier disease

Abstract Darier disease is a clinically variable rare disease with autosomal dominant inheritance caused by mutations in ATP2A2 gene. It affects skin, mucous membranes, and nails. The onset of symptoms is during adolescence and persists through adulthood, affecting quality of life. It presents papules and small malodorous keratotic yellow to brown plaques that emerge predominantly in seborrheic areas. In the present study, we describe a patient with Darier disease successfully treated with naltrexone at low doses.

Saved in:
Bibliographic Details
Main Authors: Smith-Pellegrin,Dennise L., Rivera-Vega,María R., Cazarín-Barrientos,Jorge R., Melgarejo-Gómez,Aralí, Messina-Baas,Olga M., Cuevas-Covarrubias,Sergio
Format: Digital revista
Language:English
Published: Sociedad Médica del Hospital General de México A.C. 2021
Online Access:http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S2524-177X2021000400177
Tags: Add Tag
No Tags, Be the first to tag this record!